These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16644151)

  • 1. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
    Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
    Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characteristics of quinupramine in the EVA matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2006 Aug; 320(1-2):1-3. PubMed ID: 16844330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and biopharmaceutical evaluation of quinupramine-EVA matrix containing penetration enhancer for the enhanced transdermal absorption in rats.
    Shin SC; Kim J; Kim WJ; Kim SJ; Cho CW
    Pharm Dev Technol; 2007; 12(5):429-36. PubMed ID: 17963142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
    Shin SC; Lee HJ
    Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer.
    Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC
    Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of pranoprofen from the ethylene-vinyl acetate matrix using plasticizer.
    Cho CW; Choi JS; Shin SC
    Drug Dev Ind Pharm; 2007 Jul; 33(7):747-53. PubMed ID: 17654023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release.
    Tang M; Hou J; Lei L; Liu X; Guo S; Wang Z; Chen K
    Int J Pharm; 2010 Nov; 400(1-2):66-73. PubMed ID: 20804834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
    Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Controlled Transdermal Delivery of Mexazolam Using Ethylene-vinyl Acetate.
    Weon Cho C; Chul Shin S
    Iran J Pharm Res; 2012; 11(1):3-12. PubMed ID: 25317180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of 5-fluorouridine from radiation-crosslinked poly(ethylene-co-vinyl acetate) films.
    de Queiroz AA; Abraham GA; Higa OZ
    Acta Biomater; 2006 Nov; 2(6):641-50. PubMed ID: 16876492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective layer: in vitro release, permeation and mechanical properties.
    Guo Q; Guo S; Wang Z
    J Control Release; 2007 Apr; 118(3):318-24. PubMed ID: 17289208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and release of antiviral drugs from ethylene vinyl acetate (EVA) copolymer.
    Kalachandra S; Takamata T; Lin DM; Snyder EA; Webster-Cyriaque J
    J Mater Sci Mater Med; 2006 Dec; 17(12):1227-36. PubMed ID: 17143753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of release data in the evaluation of the physical state of progesterone in matrix systems.
    Vandelli MA; Forni F; Cameroni R
    J Microencapsul; 1993; 10(1):55-65. PubMed ID: 8445508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.